First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
27.99
0.00 (0.00%)
Aug 22, 2025, 4:00 PM - Market open
FTXH Holdings Information
FTXH is an equity ETF with a total of 49 individual holdings. The top holdings are Johnson & Johnson stock at 8.12%, AbbVie at 7.51%, Pfizer at 7.30%, Merck & Co. at 6.99%, and Bristol-Myers Squibb Company at 6.09%.
Total Holdings
49
Top 10 Percentage
55.09%
Asset Class
Equity
ETF Category
Health
Assets
15.30M
PE Ratio
15.17
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | 8.12% |
| 2 | ABBV | AbbVie Inc. | 7.51% |
| 3 | PFE | Pfizer Inc. | 7.30% |
| 4 | MRK | Merck & Co., Inc. | 6.99% |
| 5 | BMY | Bristol-Myers Squibb Company | 6.09% |
| 6 | VTRS | Viatris Inc. | 4.34% |
| 7 | GILD | Gilead Sciences, Inc. | 3.81% |
| 8 | BIIB | Biogen Inc. | 3.71% |
| 9 | UTHR | United Therapeutics Corporation | 3.64% |
| 10 | AMGN | Amgen Inc. | 3.60% |
| 11 | ZTS | Zoetis Inc. | 3.49% |
| 12 | REGN | Regeneron Pharmaceuticals, Inc. | 3.20% |
| 13 | JAZZ | Jazz Pharmaceuticals plc | 3.15% |
| 14 | LLY | Eli Lilly and Company | 2.89% |
| 15 | ELAN | Elanco Animal Health Incorporated | 2.68% |
| 16 | MEDP | Medpace Holdings, Inc. | 2.58% |
| 17 | CRL | Charles River Laboratories International, Inc. | 2.01% |
| 18 | EXEL | Exelixis, Inc. | 1.98% |
| 19 | ILMN | Illumina, Inc. | 1.95% |
| 20 | HALO | Halozyme Therapeutics, Inc. | 1.70% |
| 21 | OGN | Organon & Co. | 1.69% |
| 22 | NBIX | Neurocrine Biosciences, Inc. | 1.60% |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 1.07% |
| 24 | ALNY | Alnylam Pharmaceuticals, Inc. | 0.98% |
| 25 | ALKS | Alkermes plc | 0.97% |
As of Aug 21, 2025